Showing 2,659 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C symptoms & diagnosis

WHO guidelines on hepatitis B and C testing

Editor's pick
World Health Organization
21 February 2017
Cancer

HCV Infection Linked to Nonhepatic Cancers in the Elderly

Editor's pick
Infectious Disease Advisor
21 February 2017
Hepatitis C treatment

SF working on ambitious plan to eliminate hepatitis C

Editor's pick
San Francisco Chronicle
21 February 2017
Hepatitis C treatment

Hepatitis C will be eradicated in Australia by 2026, researchers predict

Editor's pick
ABC Online
21 February 2017
Hepatitis C transmission & prevention

New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands

News
17 February 2017
Hepatitis C symptoms & diagnosis

Bridging gaps in hepatitis C awareness and diagnosis

Editor's pick
New Local Government Network
10 February 2017
Hepatitis C symptoms & diagnosis

Initial HCV test results are false positive in almost half of general population

Editor's pick
Family Practice News
8 February 2017
Harm reduction

Slamming booklet uses provocative 'Tom of Finland' images in safer injecting guide for gay men

Editor's pick
Exchange Supplies
6 February 2017
Hepatitis C transmission & prevention

High hepatitis C prevalence seen in Amsterdam PrEP study participants

News
6 February 2017
Hepatitis C treatment

Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection

News
1 February 2017
Hepatitis A

Health experts concerned by rise in hepatitis A among gay and bisexual men

Editor's pick
Gay Star News
1 February 2017
Hepatitis C treatment

HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

Editor's pick
Healio
31 January 2017
Hepatitis C treatment

Report Cites Liver Failure Risk With New Hepatitis C Drugs

Editor's pick
Medscape
31 January 2017
Hepatitis C symptoms & diagnosis

Liver cirrhosis and decompensation still on the rise among people with hepatitis C

News
31 January 2017
Hepatitis C treatment

Final yes from NICE for Gilead’s Epclusa

Editor's pick
Pharma Times
27 January 2017
Hepatitis C treatment

Is DAA treatment for hepatitis C reducing the need for liver transplants?

News
27 January 2017
New & experimental hepatitis C treatment

Two new hepatitis C therapies fast-tracked in Europe

Editor's pick
PMLive
25 January 2017
Hepatitis C treatment side-effects

Are New Drugs for Hepatitis C Safe? A Report Raises Concerns

Editor's pick
New York Times
25 January 2017
Hepatitis C treatment

Egypt combats hepatitis C epidemic with state-run scheme

Editor's pick
Financial Times
23 January 2017
Hepatitis C treatment

Japan: Hepatitis C drug fakes found in Nara drugstore chain

Editor's pick
The Japan Times
18 January 2017
Pharmaceutical industry

The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

Editor's pick
Forbes
17 January 2017
Hepatitis B

Tenofovir alafenamide approved for hepatitis B in Europe

News
17 January 2017
Hepatitis B

European Commission Grants Marketing Authorization for Gilead’s Vemlidy® (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection

Editor's pick
Gilead press release
12 January 2017
New & experimental hepatitis C treatment

Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) for Chronic Hepatitis C Achieved High SVR12 Rates in Genotype 1 Japanese Patients

Editor's pick
AbbVIe press release
9 January 2017